Nature Index Ranks The Icahn School of Medicine at Mount Sinai Among The Top Ten Most Innovative, Influential Institutions in the World
Annual Nature Index supplement ranks research institutes on influence over scientific patents.
The Icahn School of Medicine at Mount Sinai is the tenth most influential research institution in the world, according to the Nature Index 2017 Innovation supplement, which sheds light on the impact academic research is having on innovation. Published in early August, the report ranks 200 universities and research organizations based on their contributions to published research that is later cited in other organizations’ patents.
“Our ranking among the top 10 most influential research institutions in the world reflects our long-standing culture of innovation, our commitment to recruiting accomplished scientists, students and executives who can advance biomedical innovation and discovery and our transformative approach to discovery to produce radically better outcomes for patients,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “We are proud to be recognized for the profound influence our science is having on medical discovery around the world.”
The Normalized Lens Influence Metric used by the Nature Index measures the influence an institution’s research has had on innovation by calculating the citations of research articles in patents owned by third parties, rather than those owned by the institutions themselves. 36.2 percent of all the Icahn School of Medicine at Mount Sinai’s natural science articles appeared in the Nature Index, a database of author affiliation information collated from research articles published in 68 high-quality science journals. The index is compiled by Nature Research, a unit of the company that publishes the journal Nature.
The Icahn School of Medicine at Mount Sinai was joined at the top of the list by institutions with global reputations for high quality research, including Scripps Research Institute, Massachusetts Institute of Technology, and Stanford University.
“This analysis comes at a time when following the transfer of scientific knowledge into industry and the economy is a growing priority for governments and research funding agencies. For them, the need to demonstrate that publicly funded science is being used for society’s benefit is paramount,” said David Swinbanks, founder of the Nature Index.
More information about the Nature Index is available here.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Scientists Construct First Predictive Model of Inflammatory Bowel Disease
Sep 11, 2017 View All Press Releases